Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Joan R. Tymon-Rosario"'
Publikováno v:
Current Treatment Options in Oncology. 23:1804-1817
Autor:
Joan R. Tymon-Rosario, Paola Manara, Diego D. Manavella, Stefania Bellone, Tobias Max Philipp Hartwich, Justin Harold, Yang Yang-Hartwich, Margherita Zipponi, Jungmin Choi, Kyungjo Jeong, Levent Mutlu, Kevin Yang, Gary Altwerger, Gulden Menderes, Elena Ratner, Gloria S. Huang, Mitchell Clark, Vaagn Andikyan, Masoud Azodi, Peter E. Schwartz, Ludmil B. Alexandrov, Alessandro D. Santin
Publikováno v:
Gynecologic Oncology. 166:117-125
Carcinosarcoma (CS) of the ovary and uterus are highly aggressive malignancies associated with poor survival. Poly(ADP-ribose)-polymerase inhibitors (PARPi) are targeted agents impairing DNA repair via homologous-recombination-deficiency (HRD) mechan
Autor:
Emeline Aviki, Ross S. Berkowitz, Vance Broach, Leigh A. Cantrell, M. Herman Chui, William Cliby, Kevin M. Elias, Lora Hedrick Ellenson, Amanda N. Fader, Donato Callegaro Filho, Nicole D. Fleming, Michael Frumovitz, David M. Gershenson, Sushmita Gordhandas, Rachel N. Grisham, Arthur Herbst, R. Tyler Hillman, Emily Hinchcliff, Anjelica Hodgson, Neil S. Horowitz, Elizabeth Kertowidjojo, Sarah H. Kim, Anne Knisely, Katherine C. Kurnit, Barrett Lawson, Mario M. Leitao, Douglas A. Levine, Ying Liu, Beverly Long, Beryl Manning-Geist, Diana Miao, Jennifer J. Mueller, Priyadharsini Nagarajan, Roisin E. O’Cearbhaill, Katherine Peng, Preetha Ramalingam, Ravin Ratan, Gloria Salvo, Alessandro D. Santin, Aaron Shafer, Pamela Soliman, Sahana Somasegar, Joan R. Tymon-Rosario, Jason D. Wright, S. Diane Yamada, Oliver Zivanovic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e91131e1134b764aa5bbe23c84c326e
https://doi.org/10.1016/b978-0-323-82938-0.09993-6
https://doi.org/10.1016/b978-0-323-82938-0.09993-6
Publikováno v:
Current treatment options in oncologyReferences and Recommended ReadingPapers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance. 23(12)
Despite the dismal prognosis of uterine serous carcinoma (USC), recent advances in molecular classification and targeted treatments have demonstrated improvements in survival outcomes for patients both in the upfront and recurrent treatment settings.
Autor:
Stefania Bellone, Dana M. Roque, Eric R. Siegel, Natalia Buza, Pei Hui, Elena Bonazzoli, Adele Guglielmi, Luca Zammataro, Nupur Nagarkatti, Samir Zaidi, Jungsoo Lee, Dan‐Arin Silasi, Gloria S. Huang, Vaagn Andikyan, Shari Damast, Mitchell Clark, Masoud Azodi, Peter E. Schwartz, Joan R. Tymon‐Rosario, Justin A. Harold, Dennis Mauricio, Burak Zeybek, Gulden Menderes, Gary Altwerger, Elena Ratner, Ludmil B. Alexandrov, Akiko Iwasaki, Yong Kong, Eric Song, Weilai Dong, Julia A. Elvin, Jungmin Choi, Alessandro D. Santin
Publikováno v:
Cancer. 128(6)
Microsatellite instability-high (MSI-H)/mismatch repair deficiency (dMMR) is a biomarker for responses to immune checkpoint inhibitors (ICIs). Whether mechanisms underlying microsatellite instability alter responses to ICIs is unclear. This article r
Autor:
Dana M. Roque, Eric R. Siegel, Natalia Buza, Stefania Bellone, Dan-Arin Silasi, Gloria S. Huang, Vaagn Andikyan, Mitchell Clark, Masoud Azodi, Peter E. Schwartz, Gautam G. Rao, Jocelyn C. Reader, Pei Hui, Joan R. Tymon-Rosario, Justin Harold, Dennis Mauricio, Burak Zeybek, Gulden Menderes, Gary Altwerger, Elena Ratner, Alessandro D. Santin
Publikováno v:
British journal of cancer. 126(12)
This multi-center RP2 study assessed activity/safety of ixabepilone + bevacizumab compared to ixabepilone in platinum-resistant/refractory ovarian/fallopian tube/primary peritoneal cancer. Additional objectives were to examine the role of prior bevac